Alexza Pharmaceuticals Inc (NASDAQ:ALXA)

2.06
Delayed Data
As of 11:23am ET
 +0.04 / +1.98%
Today’s Change
1.25
Today|||52-Week Range
5.27
+38.26%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues5.7M4.1M47.8M5.6M
 
 
 
 
 
Cost of Goods Sold----7.9M15.9M
 
 
 
Depreciation And Amortization4.4M4.3M3.3M--
 
 
 
 
 
Operating ExpensesGross Income----36.6M-10.4M
 
 
 
General Expenses35.6M27.2M34.9M27.1M
 
 
 
 
 
Research And Development28.3M21.8M19.1M13.7M
 
 
 
 
 
Total Operating Expenses40.0M31.5M46.1M43.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-34.4M-27.5M1.8M-37.5M
 
 
 
 
 
Extraordinary Credit0.00479.0K0.008.1M
 
 
 
Extraordinary Charge-4.0M0.00-39.9M--
 
 
 
Interest Expense On Debt2.2M1.4M1.5M7.4M
 
 
 
 
 
Other Expenses0.000.000.0013.0K
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-40.5M-28.0M-39.6M-36.7M
 
 
 
 
 
Net Income-40.5M-28.0M-39.6M-36.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS6.8M12.5M16.7M--
 
 
 
 
Shares To Calculate EPS Diluted6.8M12.5M16.7M--
 
 
 
 
 
Earnings Per ShareEPS-$6.00-$2.24-$2.38-$2.07
 
 
 
 
 
EPS Diluted-$6.00-$2.24-$2.38-$2.07
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account